Teresa Baker, MD
Obstetrics & Gynecology · Amarillo, TXNPI 1023040227
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $875 of the $1,309 with a category attached, or 66.9%. Biohaven Pharmaceutical Holding Company Ltd. accounts for 66.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $972 and has fallen 98.5% since, to $15 in 2025.
Across 21 payments — averaging $62.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$875
- AbbVie$214
- Astellas Pharma US Inc$45
- Conmed Corporation$43
- Bayer$39
- Coopersurgical, Inc.$31
- plus $62 from 3 others
What the payments were for
- Consulting fees$87567%
- Food & beverage$43433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $875 |
| AbbVie(2 entities) | 11 | $214 |
| Astellas Pharma US Inc | 2 | $45 |
| Conmed Corporation | 1 | $43 |
| Bayer | 2 | $39 |
| Coopersurgical, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Merck | 1 | $22 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$875
How this compares
$1,309 in reported general payments places this provider in the 55th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 99 | $3,576 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,461 |
| Norethindrone Acetate | 24 | $333 |
| ProgesteroneProgesterone, Micronized | 22 | $246 |
| Medroxyprogesterone Acetate | 16 | $201 |
| Clobetasol Propionate | 11 | $137 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Amarillo
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.